 <h1>Dimethyl fumarate Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of dimethyl fumarate include:</b> infection, abdominal pain, and flushing. <b>Other side effects include:</b> increased serum aspartate aminotransferase, pruritus, skin rash, vomiting, lymphocytopenia, and erythema of skin.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to dimethyl fumarate: oral capsule delayed release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, dimethyl fumarate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking dimethyl fumarate:</p><p>
<i>More common</i>
</p><ul>
<li>Chills</li>
<li>cough</li>
<li>feeling of warmth</li>
<li>fever</li>
<li>hoarseness</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>chest pain</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>hives, itching, or skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>painful blisters on the trunk of the body</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>tightness in the chest</li>
<li>trouble breathing</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of dimethyl fumarate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>nausea</li>
<li>stomach pain</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Belching</li>
<li>heartburn</li>
<li>indigestion</li>
<li>stomach discomfort or upset</li>
</ul><p>
<!-- end oral capsule delayed release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dimethyl fumarate: oral delayed release capsule</i></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphopenia, leucopenia, WBC decreased</p>
<p><b>Frequency not reported</b>: Eosinophilia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Ketones in urine, 1+ or greater (45%), 1,25-dihydroxyvitamin D decreased (25%), (PTH) increased (29%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (34% to 40%)</p>
<p><b>Common</b> (1% to 10%): Hot flush<sup>[Ref]</sup></p><p>The incidence of flushing was highest early in the course of treatment (primarily in month 1) and usually decreased over time.  The majority of events were mild to moderate in severity.<sup>[Ref]</sup></p><h3>General</h3><p><b>Common</b> (1% to 10%): Feeling hot<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (14%), nausea (12%), abdominal pain (upper) (10%), abdominal pain (9% to 18%)</p>
<p><b>Common</b> (1% to 10%): Vomiting, dyspepsia, gastritis, gastrointestinal disorder, gastroenteritis<sup>[Ref]</sup></p><p>The incidence of gastrointestinal events was highest early in the course of treatment (primarily in month 1) and usually decreased over time.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, erythema<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Increases in hepatic transaminases (AST and ALT) generally occurred during the first six months of treatment, and most patients had levels less than 3 times the upper limit of normal (ULN).<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): AST increased, ALT increased<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Burning sensation<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Serious flushing<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Proteinuria (albumin)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Tecfidera (dimethyl fumarate)." Biogen Inc, Cambridge, MA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are the new drugs used for multiple sclerosis (MS)?</li>
<li>Is Tecfidera an immunosuppressant?</li>
<li>Can I stop taking Tecfidera? What happens if I do?</li>
<li>Can you drink alcohol while taking Tecfidera?</li>
<li>How long can you take Tecfidera?</li>
<li>What causes flushing with Tecfidera?</li>
<li>Gilenya vs Tecfidera. How do they compare?</li>
<li>Does Tecfidera cause weight gain or loss?</li>
<li>How long does it take Tecfidera to start working?</li>
<li>Can Tecfidera cause progressive multifocal leukoencephalopathy (PML)?</li>
<li>Can Tecfidera cause low lymphocytes?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about dimethyl fumarate</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>91 Reviews</li>
<li>Drug class: selective immunosuppressants</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Dimethyl fumarate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Tecfidera</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dimethyl fumarate: oral delayed release capsule</i></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphopenia, leucopenia, WBC decreased</p><p><b>Frequency not reported</b>: Eosinophilia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Ketones in urine, 1+ or greater (45%), 1,25-dihydroxyvitamin D decreased (25%), (PTH) increased (29%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (34% to 40%)</p><p><b>Common</b> (1% to 10%): Hot flush<sup>[Ref]</sup></p><p>The incidence of flushing was highest early in the course of treatment (primarily in month 1) and usually decreased over time.  The majority of events were mild to moderate in severity.<sup>[Ref]</sup></p><h3>General</h3><p><b>Common</b> (1% to 10%): Feeling hot<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (14%), nausea (12%), abdominal pain (upper) (10%), abdominal pain (9% to 18%)</p><p><b>Common</b> (1% to 10%): Vomiting, dyspepsia, gastritis, gastrointestinal disorder, gastroenteritis<sup>[Ref]</sup></p><p>The incidence of gastrointestinal events was highest early in the course of treatment (primarily in month 1) and usually decreased over time.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, erythema<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Increases in hepatic transaminases (AST and ALT) generally occurred during the first six months of treatment, and most patients had levels less than 3 times the upper limit of normal (ULN).<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): AST increased, ALT increased<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Burning sensation<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Serious flushing<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Proteinuria (albumin)<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Tecfidera (dimethyl fumarate)." Biogen Inc, Cambridge, MA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are the new drugs used for multiple sclerosis (MS)?</li>
<li>Is Tecfidera an immunosuppressant?</li>
<li>Can I stop taking Tecfidera? What happens if I do?</li>
<li>Can you drink alcohol while taking Tecfidera?</li>
<li>How long can you take Tecfidera?</li>
<li>What causes flushing with Tecfidera?</li>
<li>Gilenya vs Tecfidera. How do they compare?</li>
<li>Does Tecfidera cause weight gain or loss?</li>
<li>How long does it take Tecfidera to start working?</li>
<li>Can Tecfidera cause progressive multifocal leukoencephalopathy (PML)?</li>
<li>Can Tecfidera cause low lymphocytes?</li>
</ul><h2>More about dimethyl fumarate</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>91 Reviews</li>
<li>Drug class: selective immunosuppressants</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Dimethyl fumarate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>